-+ 0.00%
-+ 0.00%
-+ 0.00%

LB Pharmaceuticals FY2025 net loss narrows 60.06% to $25 million; research and development expenses fall 67.38% to $17 million

Reuters·03/26/2026 20:09:46

Please log in to view news